Research Article
Contribution to the Detection of Poor Quality Sildenafil Drugs in Burkina Faso Using High-Performance Thin-Layer Chromatography
Table 1
Characteristics of analyzed samples.
| | Drug supply circuit | Name, dosage, form | Regulatory status | Batch number | Expiry date |
| | Legal | Plaevz 50 mg tablets B/4 | Lack of marketing authorization | TET-1703 | 04/2020 | | Cupid 50 mg tablets B/1 | Valid marketing authorization | ET389E8002 | 12/2020 | | Asmoforce 50 mg tablets B/4 | Valid marketing authorization | MDTJL1701 | 05/2020 | | Erector 50 mg tablets B/1 | Valid marketing authorization | SIL05034 | 04/2020 | | Erekta 50 mg tablets B/4 | Valid marketing authorization | 7218762 | 04/2020 |
| | Illegal | Venegra 50 mg tablets B/5 | None | | Yoga 100 mg tablets B/4 | | Meinnah 120 mg tablets B/5 | | Kdgra 120 mg tablets B/5 | | Rygra 120 mg tablets B/5 |
|
|